Clinical Trials Browser

Melanoma × Immunotherapy × 90 days × Clear all

NCT02645149 2026-05-29

Match Mel

Phase 2 Completed

Melanoma

NCT06624644 2026-04-22

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Phase 2/3 Recruiting

Melanoma